Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Extracell Vesicles ; 13(7): e12478, 2024 Jul.
Article in English | MEDLINE | ID: mdl-39016173

ABSTRACT

Extracellular vesicles (EVs) serve as pivotal mediators of intercellular communication in both health and disease, delivering biologically active molecules from vesicle-producing cells to recipient cells. In the context of HIV infection, EVs have been shown to carry the viral protein Nef, a key pathogenic factor associated with HIV-related co-morbidities. Despite this recognition, the specific localisation of Nef within the vesicles has remained elusive. This study addresses this critical knowledge gap by investigating Nef-containing EVs. Less than 1% of the total released Nef was associated with EVs; most Nef existed as free protein released by damaged cells. Nevertheless, activity of EV-associated Nef in downregulating the major cholesterol transporter ABCA1, a critical aspect linked to the pathogenic effects of Nef, was comparable to that of free Nef present in the supernatant. Through a series of biochemical and microscopic assays, we demonstrate that the majority of EV-associated Nef molecules are localised on the external surface of the vesicles. This distinctive distribution prompts the consideration of Nef-containing EVs as potential targets for immunotherapeutic interventions aimed at preventing or treating HIV-associated co-morbidities. In conclusion, our results shed light on the localisation and functional activity of Nef within EVs, providing valuable insights for the development of targeted immunotherapies to mitigate the impact of HIV-associated co-morbidities.


Subject(s)
Extracellular Vesicles , HIV Infections , HIV-1 , nef Gene Products, Human Immunodeficiency Virus , Extracellular Vesicles/metabolism , Humans , nef Gene Products, Human Immunodeficiency Virus/metabolism , HIV-1/metabolism , HIV Infections/metabolism , ATP Binding Cassette Transporter 1/metabolism
2.
Hear Res ; 414: 108410, 2022 02.
Article in English | MEDLINE | ID: mdl-34915397

ABSTRACT

The primary startle response (SR) is an innate reaction evoked by sudden and intense acoustic, tactile or visual stimuli. In rodents and humans the SR involves reflexive contractions of the face, neck and limb muscles. The acoustic startle response (ASR) pathway consists of auditory nerve fibers (AN), cochlear root neurons (CRNs) and giant neurons of the caudal pontine reticular nucleus (PnC), which synapse on cranial and spinal motor neurons. The tactile startle response (TSR) is transmitted by primary sensory neurons to the principal sensory (Pr5) and spinal (Sp5) trigeminal nuclei. The ventral part of Pr5 projects directly to the PnC neurons. The SR requires rapid transmission of sensory information to initiate a fast motor response. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR) are necessary to transmit auditory information to the PnC neurons and elicit the SR. AMPARs containing the glutamate AMPAR subunit 4 (GluA4) have fast kinetics, which makes them ideal candidates to transmit the SR signal. This study examined the role of GluA4 within the primary SR pathway by using GluA4 knockout (GluA4-KO) mice. Deletion of GluA4 considerably decreased the amplitude and probability of successful ASR and TSR, indicating that the presence of this subunit is critical at a common station within the startle pathway. We conclude that deletion of GluA4 affects the transmission of sensory signals from acoustic and tactile pathways to the motor component of the startle reflex. Therefore, GluA4 is required for the full response and for reliable elicitation of the startle response.


Subject(s)
Neurons , Reflex, Startle , Acoustic Stimulation , Acoustics , Animals , Mice , Neurons/physiology , Reflex, Startle/physiology , Synapses
3.
Hear Res ; 344: 284-294, 2017 02.
Article in English | MEDLINE | ID: mdl-28011083

ABSTRACT

AMPA glutamate receptor complexes with fast kinetics conferred by subunits like GluA3 and GluA4 are essential for temporal precision of synaptic transmission. The specific role of GluA3 in auditory processing and experience related changes in the auditory brainstem remain unknown. We investigated the role of the GluA3 in auditory processing by using wild type (WT) and GluA3 knockout (GluA3-KO) mice. We recorded auditory brainstem responses (ABR) to assess auditory function and used electron microscopy to evaluate the ultrastructure of the auditory nerve synapse on bushy cells (AN-BC synapse). Since labeling for GluA3 subunit increases on auditory nerve synapses within the cochlear nucleus in response to transient sound reduction, we investigated the role of GluA3 in experience-dependent changes in auditory processing. We induced transient sound reduction by plugging one ear and evaluated ABR threshold and peak amplitude recovery for up to 60 days after ear plug removal in WT and GluA3-KO mice. We found that the deletion of GluA3 leads to impaired auditory signaling that is reflected in decreased ABR peak amplitudes, an increased latency of peak 2, early onset hearing loss and reduced numbers and sizes of postsynaptic densities (PSDs) of AN-BC synapses. Additionally, the lack of GluA3 hampers ABR threshold recovery after transient ear plugging. We conclude that GluA3 is required for normal auditory signaling, normal ultrastructure of AN-BC synapses in the cochlear nucleus and normal experience-dependent changes in auditory processing after transient sound reduction.


Subject(s)
Auditory Perception , Behavior, Animal , Cochlear Nerve/metabolism , Cochlear Nucleus/metabolism , Hearing Loss, High-Frequency/metabolism , Hearing , Receptors, AMPA/deficiency , Synapses/metabolism , Acoustic Stimulation , Adaptation, Physiological , Animals , Cochlear Nerve/physiopathology , Cochlear Nerve/ultrastructure , Cochlear Nucleus/physiopathology , Cochlear Nucleus/ultrastructure , Evoked Potentials, Auditory, Brain Stem , Genetic Predisposition to Disease , Hearing Loss, High-Frequency/genetics , Hearing Loss, High-Frequency/pathology , Hearing Loss, High-Frequency/physiopathology , Male , Mice, Inbred C57BL , Mice, Knockout , Phenotype , Reaction Time , Receptors, AMPA/genetics , Synapses/ultrastructure , Time Factors
4.
Brain Res ; 1529: 39-45, 2013 Sep 05.
Article in English | MEDLINE | ID: mdl-23891716

ABSTRACT

Many neurons degenerate after injuries resulting from overstimulation, drugs, genetic mutations, and aging. Although several growth factors and neurotrophins delay degeneration and promote regrowth of neural processes, the role of fibroblast growth factor 8 (FGF8) in mammalian spiral ganglion neurons (SGN) neurite outgrowth has not been examined. This study develops and uses SGN cell cultures suitable for experimental analysis, it investigates whether FGF8a and FGF8b isoforms affect the neurite outgrowth from SGN cultured in vitro. We found that both FGF8a and FGF8b promoted the outgrowth of neurites from cultured SGN. This response is mediated by FGF receptors and involves the activation of IκBα-mediated NFκB signaling pathway. These findings suggest that, besides its morphogenetic role during development, FGF8 may have trophic functions in the adult which are relevant to regeneration.


Subject(s)
Fibroblast Growth Factor 8/pharmacology , Neurites/drug effects , Neurons/cytology , Spiral Ganglion/cytology , Analysis of Variance , Animals , Animals, Newborn , Cells, Cultured , Doublecortin Domain Proteins , Drug Interactions , Enzyme Inhibitors/pharmacology , Fibroblast Growth Factor 8/antagonists & inhibitors , Mice , Mice, Inbred ICR , Microtubule-Associated Proteins/metabolism , Neuropeptides/metabolism , Protein Isoforms/pharmacology , Pyrimidines/pharmacology , Tubulin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...